Growth Metrics

Novartis Ag (NVS) Net Income towards Common Stockholders Growth (5y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -4.15%
Dec 31, 2023 56.23%
Sep 30, 2023 24.31%
Jun 30, 2023 2.83%
Mar 31, 2023 19.95%
Dec 31, 2022 -21.70%
Sep 30, 2022 -16.03%
Jun 30, 2022 17.06%
Mar 31, 2022 2.61%
Dec 31, 2021 -5.01%
Sep 30, 2021 3.99%
Jun 30, 2021 60.61%
Mar 31, 2021 22.68%
Dec 31, 2020 376.42%
Sep 30, 2020 48.73%
Jun 30, 2020 4,895.55%
Mar 31, 2020 1,201.75%
Mar 31, 2019 -1,044.65%
Sep 30, 2018 -1,797.08%
Jun 30, 2018 1,492.94%
Sep 30, 2017 1,512.77%
Jun 30, 2017 1,974.87%
Mar 31, 2017 1,482.48%
Dec 31, 2016 2,284.56%
Sep 30, 2016 1,478.37%
Jun 30, 2016 1,484.33%
Mar 31, 2016 1,110.09%
Dec 31, 2015 424.47%
Sep 30, 2015 960.76%
Jun 30, 2015 -15.31%
Mar 31, 2015 -31.85%
Dec 31, 2014 -294.33%
Sep 30, 2014 171.82%
Jun 30, 2014 -174.32%
Mar 31, 2014 258.33%